Clinical Trial Update: Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether the combination of alogliptin and pioglitazone preserves long-term beta-cell function in diabetes. Status of the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Alogliptin/pioglitazone (Alogliptin; Pioglitazone)

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Diabetes | Phase 4 | Status: UNKNOWN